| 1 |
Alqurashi YE, Al-Hetty HRAK, Ramaiah P, Fazaa AH, Jalil AT, Alsaikhan F, Gupta J, Ramírez-Coronel AA, Tayyib NA, Peng H. Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint. Environ Res 2023;:115683. [PMID: 36933639 DOI: 10.1016/j.envres.2023.115683] [Reference Citation Analysis]
|
| 2 |
Ghobadi N, Asoodeh A. Co-administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets. Phytother Res 2023. [PMID: 36883534 DOI: 10.1002/ptr.7794] [Reference Citation Analysis]
|
| 3 |
Bhattacharya S, Perris A, Jawed JJ, Hoda M. Therapeutic role of resveratrol against hepatocellular carcinoma: a review on its molecular mechanisms of action. Pharmacological Research - Modern Chinese Medicine 2023. [DOI: 10.1016/j.prmcm.2023.100233] [Reference Citation Analysis]
|
| 4 |
Florio R, De Filippis B, Veschi S, di Giacomo V, Lanuti P, Catitti G, Brocco D, di Rienzo A, Cataldi A, Cacciatore I, Amoroso R, Cama A, De Lellis L. Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. Int J Mol Sci 2023;24. [PMID: 36768301 DOI: 10.3390/ijms24031977] [Reference Citation Analysis]
|
| 5 |
Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, Gholami S, Ghorbani A, Tavakolpournegari A, Farsani ZM, Zarrabi A, Nabavi N, Zandieh MA, Rashidi M, Taheriazam A, Entezari M, Khan H. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacol Res 2023;187:106568. [PMID: 36423787 DOI: 10.1016/j.phrs.2022.106568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Chioreanu A, Mot IC, Horhat DI, Balica NC, Sarau CA, Morar R, Domuta EM, Dumitru C, Negrean RA, Bumbu BA, Ravulapalli M, Alambaram S, Akshay R, Pricop M. Development and Preliminary Characterization of Polyester-Urethane Microparticles Used in Curcumin Drug Delivery System for Oropharyngeal Cancer. Medicina 2022;58:1689. [DOI: 10.3390/medicina58111689] [Reference Citation Analysis]
|
